ReviewCancer cell international2023

Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer.

Zeinab Deris Zayeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.